Fumie Iwai
Kitakyushu, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Significance of Pre- and Posttransplant Minimal Residual Disease on Transplant Outcomes in Core-Binding Factor Acute Myeloid Leukemia.
Journal: European journal of haematology
Published: May 24, 2025
Post-transplant lymphoproliferative disease of two different histological types.
Journal: Annals of hematology
Published: February 15, 2024
HTLV-1 bZIP factor impairs DNA mismatch repair system.
Journal: Biochemical and biophysical research communications
Published: February 28, 2023
Allogeneic stem cell transplantation for trisomy 8-positive myelodysplastic syndrome or myelodysplastic/myeloproliferative disease with refractory Behçet's disease: Case report and the review of literature.
Journal: Modern rheumatology case reports
Published: January 17, 2022
Treatment for acute leukemia showing PCR-positivity of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) at initial diagnosis: a case report and review of literature
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: December 06, 2021
A case report of combined treatment of gilteritinib and LH-RH agonist for Fms-related tyrosine kinase 3 receptor mutation-positive acute myeloid leukemia and bone marrow metastasis of prostate cancer.
Journal: Annals of hematology
Published: February 10, 2021
LUBAC accelerates B-cell lymphomagenesis by conferring resistance to genotoxic stress on B cells.
Journal: Blood
Published: August 15, 2019
HTLV-1 bZIP factor suppresses TDP1 expression through inhibition of NRF-1 in adult T-cell leukemia.
Journal: Scientific reports
Published: May 11, 2017
Abacavir, an anti-HIV-1 drug, targets TDP1-deficient adult T cell leukemia.
Journal: Science advances
Published: December 12, 2014
Last Updated: 09/26/2026